Abstract
To determine the efficacy of azathioprine in the treatment of Crohn's disease, a 26-week double-blind trial was performed. 20 patients with Crohn's disease, requiring at least 10 mg of prednisone/day over the 3 months prior to entering the study were randomized into placebo (10 patients) and azathioprine (10 patients) treatment groups. Reduction of steroids was the major criterion of success in the trial. There were 7 relapses in the placebo group (5 patients) and 2 relapses in the azathioprine group (2 patients). Complications including fistulae were not affected by the medications. The mean reduction in steroid dosage in the azathioprine group at the end of the trial (−15.5 mg) was greater than in the placebo group (−6.1 mg). These results suggest that azathioprine may permit reduction or discontinuation of steroids without the worsening of symptoms in some patients who appear to require steroids for control of their symptoms. The clinical features of this “AZA-responsive subgroup” remain to be defined.
Similar content being viewed by others
References
Brooke BN, Hoffman DC, Swarbrick ET: Azathioprine for Crohn's disease. Lancet 2:612–614, 1969
Brooke BN, Javett SL, Davison OW: Further experience with azathioprine for Crohn's disease. Lancet 2:1050–1053, 1973
Patterson JF, Horton RA, Schwartz RS: Azathioprine treatment of ulcerative colitis, granulomatous colitis, and regional enteritis. Am J Dig Dis 16:327–332, 1971
Drucker WR, Jeejeebhoy KN: Azathioprine: An adjunct to surgical therapy of granulomatous enteritis. Ann Surg 172:618–625, 1970
Willoughby JMT, Parveen KJ, Beckett J, Dawson AM: Controlled trial of azathioprine in Crohn's disease. Lancet 2:944–946, 1971
Rhodes J, Bainton D, Beck P, Campbell H: Controlled trial of azathioprine in Crohn's disease. Lancet 2:1273–1276, 1971
Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H: Treatment of Crohn's disease with azathioprine: A controlled evaluation. Gastroenterology 66:916–922, 1974
Rosman M, Bertino JR: Azathioprine. Ann Intern Med 79:694–700, 1973
Rosenberg JL, Wall AJ, Settles RH, Binder HJ, Levin B, Kirsner JB. A controlled trial of azathioprine in the treatment of chronic ulcerative colitis. Gastroenterology 64:793, 1973
Treatment of Crohn's disease (editorial). Lancet 2:695–696, 1971
Walden BK, Robertson MR, Jeremy D: Skin cancer and immunosuppression. Lancet 2:1282–1283, 1971
Doll R, Kinlen L: Immunosurveillance and cancer: Epidemiological evidence. Br Med J 4:420–422, 1970
Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF: Crohn's disease and cancer. N Engl J Med 289:1099–1103, 1973
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Gastrointestinal Research Foundation of Chicago and the L. Sinton Fund.
Rights and permissions
About this article
Cite this article
Rosenberg, J.L., Levin, B., Wall, A.J. et al. A controlled trial of azathioprine in Crohn's disease. Digest Dis Sci 20, 721–726 (1975). https://doi.org/10.1007/BF01070829
Issue Date:
DOI: https://doi.org/10.1007/BF01070829